ArticleCells2025

Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer.

Ju Yeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.